Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EC50 of Ciprofol Combined With Remifentanil for Inhibiting Tracheal Responses
NCT07462949Completed
- Sponsor
- General Hospital of Southern Theater Command of the People's Liberation Army
- Start
- Mar 2026
- Primary completion
- Apr 2026
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
Trial of ciprofol and remifentanil (2 arms), sponsored by General Hospital of Southern Theater Command of the People's Liberation Army. Primary endpoints: Half-effective concentration, Heart rate and 2 more. Started Mar 2026; status: completed.
02
Drugs
ciprofolremifentanil
Beyond the preview
Go deeper on NCT07462949.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07462949.